Minerva Neurosciences, Inc. (NERV) stock
NERVNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.30−0.08 (-3.36%)
Close on Nov 13, 2026Market cap $109.82MP/E –Yield –
Minerva Neurosciences ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Minerva Neurosciences's ebitda for the twelve months ending Dec 31, 2025 was -$15.10M. For fiscal 2025 it was -$15.10M. The highest annual figure on record is $1.86M in fiscal 2020.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$15.10M | – |
| FY2024 | Dec 31, 2024 | -$21.84M | – |
| FY2023 | Dec 31, 2023 | -$23.11M | -1340.9% |
| FY2020 | Dec 31, 2020 | $1.86M | – |
| FY2019 | Dec 31, 2019 | -$75.85M | – |
| FY2018 | Dec 31, 2018 | -$51.71M | – |
| FY2017 | Dec 31, 2017 | -$41.16M | – |
| FY2016 | Dec 31, 2016 | -$30.17M | – |
| FY2015 | Dec 31, 2015 | -$26.09M | – |
| FY2014 | Dec 31, 2014 | -$54.84M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -$4.98M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.84M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.37M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.90M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.52M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.37M | – |
| Q2 FY2024 | Jun 30, 2024 | -$6.28M | – |
| Q1 FY2024 | Mar 31, 2024 | -$6.68M | – |
| Q4 FY2023 | Dec 31, 2023 | -$7.17M | – |
| Q3 FY2023 | Sep 30, 2023 | -$6.08M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.52M | -115.3% |
| Q1 FY2023 | Mar 31, 2023 | -$5.35M | – |
| Q4 FY2020 | Dec 31, 2020 | -$7.30M | – |
| Q3 FY2020 | Sep 30, 2020 | -$8.09M | – |
| Q2 FY2020 | Jun 30, 2020 | $29.51M | – |
| Q1 FY2020 | Mar 31, 2020 | -$12.27M | – |
| Q4 FY2019 | Dec 31, 2019 | -$32.36M | – |
| Q3 FY2019 | Sep 30, 2019 | -$14.28M | – |
| Q2 FY2019 | Jun 30, 2019 | -$12.90M | – |
| Q1 FY2019 | Mar 31, 2019 | -$16.31M | – |
| Q4 FY2018 | Dec 31, 2018 | -$13.62M | – |
| Q3 FY2018 | Sep 30, 2018 | -$12.42M | – |
| Q2 FY2018 | Jun 30, 2018 | -$12.93M | – |
| Q1 FY2018 | Mar 31, 2018 | -$12.74M | – |
| Q4 FY2017 | Dec 31, 2017 | -$9.53M | – |
| Q3 FY2017 | Sep 30, 2017 | -$11.40M | – |
| Q2 FY2017 | Jun 30, 2017 | -$9.74M | – |
| Q1 FY2017 | Mar 31, 2017 | -$10.48M | – |
| Q4 FY2016 | Dec 31, 2016 | -$9.23M | – |
See a number that looks wrong?